HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A worrying development in the microbiology of otitis externa.

Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is causing growing concern in hospitals. There has been a steady increase in the number of cases of nosocomial MRSA infections recently and this will no doubt apply to otitis externa, one of the most common ENT infections. The total number of cases of otitis externa presenting to the Accident and Emergency Department over a 3-month period was recorded and the offending microbes cultured and tested for drug sensitivities. Although Pseudomonas aeruginosa was the most frequent organism, 30% of patients grew S. aureus. Of these, 6% (15 patients) were MRSA cultures. The contact histories, antibiotic sensitivities and treatment of these 15 patients were studied. Recommendations as a result of this study include the routine culture and sensitivity in otitis externa and where MRSA is cultured, a full contact history should be elicited and appropriate precautions taken. Specifically, a history of hospital contact should be sought. Treatments used successfully in the treatment of MRSA otitis externa were aural toilet and fucidic acid-betamathasone 0.5% wicks where the organism was gentamycin-resistant (GMRSA), whereas aural toilet with aminoglycoside-steroid drops was sufficient if it was gentamycin-sensitive.
AuthorsP Walshe, H Rowley, C Timon
JournalClinical otolaryngology and allied sciences (Clin Otolaryngol Allied Sci) Vol. 26 Issue 3 Pg. 218-20 (Jun 2001) ISSN: 0307-7772 [Print] England
PMID11437845 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Gentamicins
  • Teicoplanin
  • Tetracycline
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Drug Resistance, Microbial
  • Female
  • Gentamicins (pharmacology)
  • Humans
  • Methicillin Resistance
  • Microbial Sensitivity Tests
  • Middle Aged
  • Otitis Externa (drug therapy, microbiology)
  • Staphylococcal Infections (drug therapy)
  • Staphylococcus aureus (drug effects)
  • Teicoplanin (therapeutic use)
  • Tetracycline (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: